gvtcx

Human Papillomavirus (2025)

UK Health Security Agency Published 16 Oct 2025 Contracts Finder

key details

Statuscomplete
Category (CPV) 33651600
Deadline4 Dec 2024
Contract start1 Dec 2025
Contract end30 Nov 2029
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-68eba892-08bc-4cf4-b8b4-34aef5a483d4

Award

SupplierValueDateStatus
Merck Sharpe & Dohme (UK) Limited £1 9 Oct 2025 active

description

Contract for the supply of human papillomavirus vaccine to be used as part of the national immunisation programme. Deliveries will be required for a four year period from December 2025

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Oct 2025 Award (award) · eaae25d5-ed83-400f-b440-7250059676c7-868413

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.